This inventor holds 1 USPTO granted patent. Top assignees: Chongqing Pharmaceutical Research Institute Co., Ltd, Yaopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Meibi Dai: Innovator in Pharmaceutical Chemistry
Introduction
Meibi Dai is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on fluvatinib.
Latest Patents
Meibi Dai holds a patent for a crystalline form of fluvatinib or fluvatinib methanesulfonate. This invention discloses a crystalline form of fluvatinib that exhibits characteristic diffraction peaks. The patent also details a preparation method for this crystalline form. The crystalline form of fluvatinib methanesulfonate can exist in multiple forms, including seven distinct crystalline forms, labeled I-VII. Notably, crystalline form III has its own unique diffraction peaks. These crystalline forms are particularly suited for manufacturing processes related to fluvatinib methanesulfonate formulations. He has 1 patent to his name.
Career Highlights
Throughout his career, Meibi Dai has worked with prominent organizations in the pharmaceutical industry. He has been associated with the Chongqing Pharmaceutical Research Institute Co., Ltd. and Yaopharma Co., Ltd. His work in these institutions has contributed to advancements in drug formulation and development.
Collaborations
Meibi Dai has collaborated with several professionals in his field, including Shuai He and Yang Zhang. These collaborations have likely enhanced his research and development efforts.
Conclusion
Meibi Dai is a distinguished inventor whose work on fluvatinib has made a significant impact in pharmaceutical chemistry. His innovative contributions continue to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile